| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $171.5M | +166.7% |
| SG&A Expense | $165.1M | -6.6% |
| Operating Income | -$347.4M | +3.0% |
| Pre-tax Income | -$317.3M | +8.8% |
| Net Income | -$317.3M | +8.8% |
| EPS (Basic) | -$1.32 | +58.0% |
| EPS (Diluted) | -$1.32 | +58.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69.4M | -90.7% |
| Current Assets | $545.5M | -27.7% |
| Total Assets | $573.8M | -25.3% |
| Current Liabilities | $53.3M | +88.3% |
| Long-term Debt | $9.3M | -50.5% |
| Total Liabilities | $80.5M | +15.8% |
| Stockholders' Equity | $493.3M | -29.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$200.4M | -84.9% |
| Capital Expenditures | $6.9M | +97.1% |
| Investing Cash Flow | -$464.3M | — |
| Financing Cash Flow | -$9.9M | -101.2% |
| Free Cash Flow | -$207.3M | -85.3% |